The UConn Board of Trustees has approved the appointment of José Manautou, Department Head of Pharmaceutical Sciences and Professor of Pharmacology & Toxicology, as the School of Pharmacy’s new Boehringer-Ingelheim Pharmaceuticals, Inc. Chair in Mechanistic Toxicology.
The endowed chair was established in 2006 with a gift of $1.2 million from Boehringer-Ingelheim Pharmaceuticals Inc., a division of Ridgefield, Connecticut based Boehringer-Ingelheim Corporation.
Manautou is recognized internationally as a scholar and leader in toxicology. His long-term research interests are on biochemical and molecular mechanisms of xenobiotic-induced hepatotoxicity and on defining compensatory responses to liver injury leading to toxicant adaptation and tolerance.